Table 2

Imaging evidence of lesion reperfusion or arterial recanalisation and associations with clinical outcomes

ParameterReperfusionCT or MR perfusion: evidence of reperfusion on:CTA or MRA: recanalisation composite measure
Tmaxp ValueCBFp ValueCBVp Valuep Value
NIHSS day 7 (median, IQR)Yes6 (3, 11.5)0.0666 (3, 13)0.156 (3, 10.5)0.304.50 (2, 7)0.044
No3 (1, 6)3 (1, 7)3 (1, 7)9 (3.5, 13.5)
NIHSS 1 month (median, IQR)Yes2 (1, 5)0.112 (1, 6)0.0642 (1, 6)0.161 (0, 3)0.00065
No1 (0, 3)1 (0, 3)1.5 (0, 3)5 (3, 11)
mRS at 3 months (median, IQR)Yes3 (2, 4)0.0763 (2, 4)0.0673 (2, 4)0.112 (1, 3)0.028
No2 (1, 3)2 (1, 3)2 (1, 3)3 (2, 4)
Age, years (median, IQR)Yes74 (65, 82)0.07474 (65, 82)0.04775 (67, 83)0.008570 (63, 79)0.58
No68 (60, 77)69 (51, 74)67 (51, 72)70 (63, 77)
  • p Values are for the Wilcoxon–Mann–Whitney test comparing groups with/without reperfusion/recanalisation.

  • CBF, cerebral blood flow; CBV, cerebral blood volume; CTA, CT angiography; MR, magnetic resonance; MRA, MR angiography; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.